Showing results (1311-1320 of 1,512) with videos related to
Sort By:
Pageof 152
Lung Cancer (Amsterdam, Netherlands)|August 9, 2021
Anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody quavonlimab in combination with pembrolizumab: Safety and efficacy from a phase I study in previously treated extensive-stage small cell lung cancerByoung Chul Cho, Kiyotaka Yoh, Ruth Perets, et al.Plos One|June 23, 2020
Mediation of the relationship between proteinuria and serum phosphate: Insight from the KNOW-CKD studyJi Yong Jung, Han Ro, Jae Hyun Chang, et al.Oncotarget|February 20, 2016
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinomaChan-Young Ock, Sehui Kim, Bhumsuk Keam, et al.Translational Psychiatry|May 10, 2022
Associations of plasma angiostatin and amyloid-β and tau levels in Alzheimer's diseaseYuan Cheng, Jun-Rong Ren, Jie-Ming Jian, et al.Cancer|December 21, 2016
Optimal timing of influenza vaccination during 3-week cytotoxic chemotherapy cyclesBhumsuk Keam, Min-Kyung Kim, Yunhee Choi, et al.Clinical Pharmacokinetics|December 11, 2023
Evaluation of the Effect of Lorlatinib on CYP2B6, CYP2C9, UGT, and P-Glycoprotein Substrates in Patients with Advanced Non-Small Cell Lung CancerJoseph Chen, Alessandra Bearz, Dong-Wan Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicityZachary C Hartman, Junping Wei, Takuya Osada, et al.Japanese Journal of Clinical Oncology|December 8, 2005
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancerKeun-Wook Lee, Seock-Ah Im, Tak Yun, et al.Annals of Hematology|January 28, 2009
Risk factors for poor treatment outcome and central nervous system relapse in diffuse large B-cell lymphoma with bone marrow involvementKeun-Wook Lee, Jongyoun Yi, In Sil Choi, et al.Journal of Breast Cancer|January 25, 2013
Body mass index is not associated with treatment outcomes of breast cancer patients receiving neoadjuvant chemotherapy: korean dataKyung-Hun Lee, Bhumsuk Keam, Seock-Ah Im, et al.Pageof 152